Overview
Frankfurt, June 23, 2020 – McDermott Will & Emery advised the joint bookrunner on the successful share placement of CompuGroup Medical SE & Co. KGaA (“CompuGroup”), one of the leading eHealth companies in the world.
CompuGroup, successfully implemented its capital measure by way of an accelerated bookbuild transaction in which the pre-emptive rights of the existing shareholders were excluded. A total of 5,321,935 shares were placed at a price of EUR 64.00 per share. The gross proceeds of the placement amount to approx. EUR 341 million. 4,806,709 treasury shares of the Company (corresponding to approx. 9.03% of CompuGroup’s share capital) were sold in the offering. The 515,226 placed shares attributable to the capital increase (corresponding to approx. 0.97% of the share capital) were made available for the purpose of implementing the transaction by way of a share loan, granted by GT 1 Vermögensverwaltung GmbH, the investment vehicle of the CompuGroup’s major shareholder Mr Frank Gotthardt.
The proceeds from the offering will serve to strengthen the equity base of CompuGroup and will provide financial flexibility to continue its growth strategy.
McDermott’s team was led by Simon Weiß and included Joseph W. Marx, Dr. Maximilian Clostermeyer, Edwin Laurenson, and Tina Zeller.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective – and often unexpected – solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
